title: Reversible kinase and phosphatase regulation of brain amino acid receptors in postnatal development.
abstract: In a previous study [Shaw, C., Pasqualotto, B. and Lanius, R.A., Mol. Neuropharmacol., in press] we have shown that phosphorylation and dephosphorylation actions of protein kinase and alkaline phosphatase lead to decreases or increases in the number of GABAA and AMPA receptors in adult rat neocortex. Using the same in vitro cortical slice preparation, we have now examined the role of these enzymes in regulating GABAA and AMPA receptors at different stages of postnatal development. GABAA receptors were labelled with [3H]SR95531 [Shaw, C. and Scarth, B.A., Mol. Brain Res., 11 (1991) 273-282]; AMPA receptors were labelled with [3H]CNQX [Lanius, R.A. and Shaw, C., Mol. Brain Res., 15 (1992) 256-262]. At postnatal day 14, GABAA receptors showed a decrease in binding in response to alkaline phosphatase treatment as opposed to an increase in binding observed in response to protein kinase treatment. Similar effects were observed for AMPA receptors at 20 days of age. The direction of regulation following the enzyme treatments were opposite to those observed in the adult cortex for both receptor populations. These fundamental changes in the enzymatic nature of regulation for such key inhibitory and excitatory receptor populations in cortex may signal an important role for age-dependent kinases and phosphatases in the events leading to modifications in neuronal function during postnatal development.
authors.affiliation: Department of Ophthalmology, University of British Columbia, Vancouver, Canada.
authors.forename: C A
authors.initials: CA
authors.lastname: Shaw
authors.forename: R A
authors.initials: RA
authors.lastname: Lanius
mesh_terms: D000469:Alkaline Phosphatase / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D002540:Cerebral Cortex / Q000254:growth & development / Q000378:metabolism*; D004594:Electrophysiology; D058787:GABA-A Receptor Antagonists; D008297:Male; D010766:Phosphorylation; D011494:Protein Kinases / Q000494:pharmacology*; D011724:Pyridazines / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA; D011963:Receptors, GABA-A / Q000378:metabolism* / Q000502:physiology; D017470:Receptors, Glutamate / Q000378:metabolism* / Q000502:physiology
chemical_list: D058787:GABA-A Receptor Antagonists; D011724:Pyridazines; D018091:Receptors, AMPA; D011963:Receptors, GABA-A; D017470:Receptors, Glutamate; C049853:gabazine; D011494:Protein Kinases; D000469:Alkaline Phosphatase